Alkemy Capital Investments
Plc
Interim Results for the Six
Month Ended 31 July 2024
Alkemy Capital Investments plc
("Alkemy" or the "Company") announces its unaudited financial
statements for the 6 months ended 31 July 2024 ("Financial
Statements").
Chairman's Statement
I have great pleasure in presenting
our interim results for the period ended 31 July 2024.
Since the inception of Alkemy, its
wholly-owned subsidiary Tees Valley Lithium (TVL) has made
excellent progress in advancing its key lithium refinery project in
Teesside, receiving planning and environmental permissions,
securing feedstock and establishing other key strategic
partnerships along with key governmental, industry and media
recognition, reflecting its commitment to becoming a leader in the
low-carbon production of battery-grade lithium
hydroxide.
Despite recent market shifts,
European demand for lithium remains on an unprecedented upward
trajectory. As Europe's car makers make the switch to EVs to meet
this burgeoning demand there is over 700GW of gigafactory capacity
either in construction or planned to provide the batteries for
these EVs. These gigafactories will require over 650,000
tonnes of locally refined lithium per year in the form of either
hydroxide or carbonate depending on the type of vehicle. Currently
the UK and Europe has very limited lithium refining
capacity.
TVL's processing refinery in
Teesside is expected to produce enough lithium hydroxide to supply
100% of the forecasted automotive demand in the UK by 2030, with a
further 35% of its total production available for export to other
countries in Europe and elsewhere.
TVL has reached an agreement in
principle with international trading house Wogen for the supply of
technical grade lithium carbonate to TVL's merchant refinery in
Teesside. Wogen is a leading international trader of off-exchange
specialty metals and minerals, with a long history and
well-established presence in the battery metals market across Asia,
the United States and Europe. Wogen intends to supply up to 20,000
tonnes of technical grade lithium carbonate feedstock per annum,
for an initial period of five years. The supply will be sufficient
to fill the first of TVL's proposed four trains, producing around
24,000 tonnes of battery grade lithium hydroxide or lithium
carbonate equivalent.
Having secured feedstock for its
first train, TVL is now focussed on obtaining initial mezzanine
funding which will enable it to complete Front End Engineering
Design (FEED) and commence the purchase of key long lead items for
the refinery. TVL is currently making good progress in these
discussions and expects to make further announcements on this front
in the short term.
Building on the successful
foundations laid by TVL, Alkemy will continue to explore new
horizons in the battery minerals sector to encompass a range of
critical battery minerals, positioning it as a diversified leader
in the energy transition sector, however the immediate focus will
remain on securing funding for TVL.
During the period we have continued
to make significant progress in a challenging macro
environment.
The pace to decarbonise however
continues to accelerate and with a growing need for lithium
hydroxide and now a growing preference from western OEM's to source
lithium hydroxide using more local supply chains, Alkemy is well
positioned to benefit from these changes.
The support received from third
parties including major OEMs provides validation of our proposed
lithium refining strategy. The rapid completion of due diligence to
the satisfaction of certain OEMs is testament to the quality of the
work undertaken by our commercial and technical teams and confirms
our wider business case.
We would like to take this
opportunity to thank our shareholders for their continued support
and patience and look forward to reporting on our progress during
2024 as we deliver on our strategy.
Paul Atherley
Non-Executive Chairman
2
October 2024
STATEMENT OF COMPREHENSIVE
INCOME
for the period ended 31 July
2024
|
|
|
|
|
|
For six months
ended
31 July 2024
(unaudited)
|
|
For the six months ended 31
July 2023
(unaudited)
|
Year ended 31 January 2024
(audited)
|
|
|
|
|
|
|
|
£
|
|
£
|
£
|
|
|
|
|
|
Note
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
|
|
|
|
|
|
-
|
|
-
|
1,247
|
|
Administrative expenses
|
|
|
|
|
|
(563,812)
|
|
(947,423)
|
(1,454,195)
|
|
Project Development costs
|
|
|
|
|
|
(91,845)
|
|
(215,461)
|
(634,288)
|
|
Business Development
costs
|
|
|
|
|
|
-
|
|
-
|
(1,852)
|
|
Finance costs
|
|
|
|
|
|
(22,059)
|
|
-
|
(1,697)
|
|
Foreign exchange gains /
(losses)
|
|
|
|
|
|
667
|
|
960
|
(5,215)
|
|
Loss before taxation
|
|
|
|
|
|
(677,049)
|
|
(1,161,924)
|
(2,096,000)
|
|
|
|
|
Income tax
|
|
|
|
|
|
-
|
|
95,278
|
325,018
|
|
Loss after taxation
|
|
|
|
|
|
(677,049)
|
|
(1,066,646)
|
(1,770,982)
|
|
Other Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange gains / (losses) on
translation of foreign operations
|
|
|
|
|
|
(9,707)
|
|
6,609
|
(2,306)
|
|
Total other comprehensive income
|
|
|
|
|
|
(9,707)
|
|
6,609
|
(2,306)
|
|
Total comprehensive loss
for
the year
|
|
|
|
|
|
(686,756)
|
|
(1,060,037)
|
(1,773,288)
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share
|
|
|
|
9
|
|
|
|
|
|
|
Basic and diluted (£
per
share)
|
|
|
(7.7p)
|
|
(14.8p)
|
(23.4p)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
The accompanying notes
form an integral part of the financial
information.
STATEMENT OF FINANCIAL
POSITION
As
at 31 July 2024
|
|
|
Note
|
|
At 31 July 2024
(unaudited)
|
At 31 July
2023
(unaudited)
|
At 31 January 2024
(audited)
|
|
|
|
|
|
£
|
£
|
£
|
ASSETS
|
|
|
|
|
|
|
|
Non current assets
|
|
|
|
|
|
|
|
Intangibles - Project development
costs
|
|
|
|
|
317,089
|
302,499
|
317,089
|
Total Non current assets
|
|
|
|
|
317,089
|
302,499
|
317,089
|
Current assets
|
|
|
|
|
|
|
|
Trade and other
receivables
|
|
|
8
|
|
97,749
|
392,298
|
126,303
|
Cash and cash equivalents
|
|
|
|
|
51,114
|
40,307
|
45,458
|
Total current assets
|
|
|
|
|
148,863
|
432,605
|
171,761
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
465,952
|
735,104
|
488,850
|
|
|
|
|
|
|
|
|
EQUITY
|
|
|
|
|
|
|
|
Equity Attributable
to
Owners of the
company
|
|
|
|
|
|
|
|
Share capital
|
|
|
10
|
|
176,297
|
144,000
|
176,297
|
Share premium
|
|
|
|
|
4,261,626
|
2,413,243
|
4,261,626
|
Share based payments
|
|
|
|
|
377,791
|
126,053
|
259,771
|
Foreign exchange reserve
|
|
|
|
|
(14,658)
|
3,964
|
(4,951)
|
Share to issue reserve
|
|
|
|
|
-
|
872,162
|
-
|
Retained earnings
|
|
|
|
|
(5,890,440)
|
(4,509,055)
|
(5,213,391)
|
Total equity
|
|
|
|
|
(1,089,384)
|
(949,633)
|
(520,648)
|
|
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
Trade and other payables
|
|
|
11
|
|
1,101,997
|
1,323,448
|
907,209
|
Borrowings
|
|
|
|
|
453,339
|
361,289
|
102,289
|
Total current liabilities
|
|
|
|
|
1,555,336
|
1,684,737
|
1,009,498
|
|
|
|
|
|
|
|
|
TOTAL EQUITY AND LIABILITIES
|
|
|
|
|
465,952
|
735,104
|
488,850
|
This report was approved by the
board and authorised for issue on 2 October 2024 and signed on its
behalf by:
Paul Atherley
Non-Executive Chairman
The accompanying notes
form an integral part of the financial
information.
STATEMENT OF CHANGES IN
EQUITY
for the year ended 31 July
2024
|
Share
capital
|
Share
Premium
|
Share Based
Payments
|
Shares to Issue
Reserve
|
Foreign Exchange
Reserve
|
Retained
Earnings
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
£
|
£
|
As
at 1 February 2023
|
144,000
|
2,413,243
|
63,221
|
-
|
(2,645)
|
(3,442,409)
|
(824,590)
|
|
|
|
|
|
|
|
|
Loss for the year
|
-
|
-
|
-
|
-
|
-
|
(1,066,646)
|
(1,066,646)
|
Foreign exchange losses on
translation of overseas subsidiaries
|
-
|
-
|
-
|
-
|
6,609
|
-
|
6,609
|
Total Comprehensive income
|
-
|
-
|
-
|
-
|
6,609
|
(1,066,646)
|
(1,060,037)
|
Transactions with owners:
|
|
|
|
|
|
|
|
Issue of shares
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Issue of options
|
-
|
-
|
62,832
|
-
|
-
|
-
|
62,832
|
Shares to issue
|
-
|
-
|
-
|
872,162
|
-
|
-
|
872,162
|
Total transactions with owners
|
-
|
-
|
62,832
|
872,162
|
-
|
-
|
934,994
|
|
|
|
|
|
|
|
|
Balance at 31 July 2023
|
144,000
|
2,413,243
|
126,053
|
872,162
|
3,694
|
(4,509,055)
|
(949,633)
|
|
Share
capital
|
Share
Premium
|
Share Based
Payments
|
Shares to Issue
Reserve
|
Foreign Exchange
Reserve
|
Retained
Earnings
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
£
|
£
|
As
at 1 February 2024
|
176,297
|
4,261,626
|
259,771
|
-
|
(4,951)
|
(5,213,391)
|
(520,648)
|
|
|
|
|
|
|
|
|
Loss for the year
|
-
|
-
|
-
|
-
|
-
|
(677,049)
|
(677,049)
|
Foreign exchange losses on
translation of overseas subsidiaries
|
-
|
-
|
-
|
-
|
(9,707)
|
-
|
(9,707)
|
Total Comprehensive income
|
-
|
-
|
-
|
-
|
(9,707)
|
(677,049)
|
(686,756)
|
Transactions with owners:
|
|
|
|
|
|
|
|
Issue of options
|
-
|
-
|
118,020
|
-
|
-
|
-
|
118,020
|
|
|
|
|
|
|
|
|
Total transactions with owners
|
-
|
-
|
118,020
|
-
|
-
|
-
|
118,020
|
|
|
|
|
|
|
|
|
Balance at 31 July 2024
|
176,297
|
4,261,626
|
377,791
|
-
|
(14,658)
|
(5,890,440)
|
(1,089,384)
|
The accompanying notes
form an integral part of the financial
information.
STATEMENT OF
CASHFLOWS
for the period ended 31 July
2024
|
|
|
|
|
Six months
ended
31 July 2024
(unaudited)
|
Six months
ended
31 July 2023
(unaudited)
|
|
Year ended 31 January 2024
(audited)
|
|
|
|
|
|
£
|
£
|
|
£
|
|
|
|
|
|
|
|
|
|
Loss before tax
|
|
|
|
|
(677,049)
|
(1,066,646)
|
|
(1,770,982)
|
Adjusted
for:
|
|
|
|
|
|
|
|
|
Share based payments
|
|
|
|
|
118,020
|
62,832
|
|
196,550
|
Expenditure met directly by funding
provider
|
|
|
|
|
-
|
35,000
|
|
-
|
Finance costs
|
|
|
|
|
22,059
|
-
|
|
-
|
(Increase)/decrease in
receivables
|
|
|
|
|
28,554
|
(180,173)
|
|
85,822
|
(Decrease)/Increase in trade
creditors
|
|
|
|
|
206,788
|
301,853
|
|
(132,662)
|
Net
cash used in operating activities
|
|
|
|
|
(301,628)
|
(847,134)
|
|
(1,621,272)
|
|
|
|
|
|
|
|
|
|
Investing activities
|
|
|
|
|
|
|
|
|
Payments for intangible
assets
|
|
|
|
|
-
|
(3,686)
|
|
-
|
Net
cash outflow from investigating activities
|
|
|
|
|
-
|
(3,686)
|
|
-
|
|
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
|
|
|
Repayment of Borrowings
|
|
|
|
|
-
|
-
|
|
(224,000)
|
Funds received against shares to
issue
|
|
|
|
|
-
|
872,162
|
|
-
|
Cash from issue of Ordinary
shares
|
|
|
|
|
-
|
-
|
|
1,880,680
|
Proceeds from short term
borrowings
|
|
|
|
|
318,900
|
-
|
|
-
|
Interest paid
|
|
|
|
|
(1,909)
|
-
|
|
-
|
Net
cash from financing activities
|
|
|
|
|
316,991
|
872,162
|
|
1,656,680
|
|
|
|
|
|
|
|
|
|
Net
(decrease)/increase in cash and cash equivalents
|
|
|
|
|
15,363
|
21,342
|
|
35,408
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of the
year
|
|
|
|
|
45,458
|
12,356
|
|
12,356
|
Effects of foreign exchange on cash
balances
|
|
|
|
|
(9,707)
|
6,609
|
|
(2,306)
|
Cash and cash equivalents at end of the year
|
|
|
|
|
51,114
|
40,307
|
|
45,458
|
|
|
|
|
|
|
|
|
| |
The accompanying notes
form an integral part of the financial
information.
NOTES TO THE FINANCIAL INFORMATION
1. GENERAL
INFORMATION
The Company was incorporated on 21
January 2021 in England and Wales as a public company, limited by
shares and with Registered Number 13149164 under the Companies Act
2006. On incorporation, the Company's name was Alkemy Capital Plc.
On 4 February 2021, the Company's name was changed to Alkemy
Capital Investments Plc. The Company's registered office address is
167-169 Great Portland Street, Fifth Floor, London W1W 5PF. On 25
February 2022 the Company formed a wholly owned subsidiary called
Tees Valley Lithium Limited, a company seeking to establish a
Lithium Hydroxide Monohydrate ("LHM") processing facility in
Teesside, UK.
The Company's objective is to establish a LHM
processing plant at its chosen site in Teesside, UK which will aim
to initially produce LHM from lithium feedstock from various
sources, to be sold to the UK and European mobile energy
markets.
In August 2022 the Company announced
plans to build a lithium sulphate monohydrate plant at Port
Hedland, Australia's largest export port located in the Pilbara
region of Western Australia, to feed TVL's LHM facility in Teesside
and in September 2022 the Company formed a wholly owned subsidiary
called Port Hedland Lithium Pty Ltd.
Other than the Directors, the
Company has no employees.
The Directors who served during the
period were Sam Quinn, Paul Atherley, Helen Pein and Vikki
Jeckell.
2. ACCOUNTING
POLICIES
Basis of
preparation
The principal accounting policies
adopted by the Company in the preparation of the Company Financial
Information are set out below.
The Company Financial Information
has been presented in £, being the functional currency of the
Company.
The Company Financial Information
has been prepared in accordance with IFRS, including
interpretations made by the International Financial Reporting
Interpretations Committee issued by the International Accounting
Standards Board. The standards have been applied consistently. The
historical cost basis of preparation has been used.
The preparation of the financial
statements in conformity with IFRS requires the use of certain
critical accounting estimates. It also requires the Directors to
exercise their judgment in the process of applying the Company's
accounting policies.
In the opinion of the management,
the interim unaudited financial information includes all
adjustments considered necessary for fair and consistent
presentation of this financial information. The interim unaudited
financial information should be read in conjunction with the
Company's audited financial statements and notes for the year ended
31 January 2024.
Standards and interpretations
issued but not yet applied
A number of new standards and
amendments to standards and interpretations have been issued but
are not yet effective and, in some cases, have not yet been adopted
by the UKEU. The Directors do not expect that the adoption of these
standards will have a material impact on the Company Financial
Information.
Going
Concern
As part of their assessment of going
concern, the Directors have prepared cash forecasts to determine
the funding requirements of the business over the 18 months from
the reporting date. Cash requirements over this period have been
projected in the range of a £2m minimum (decelerated project
development case) to £9m maximum (accelerated project development
case) depending on the level of technical project development work
being undertaken, as determined by funding availability.
As at the date of this report, the
Directors are considering a variety of funding options from
numerous parties to consider the option best suited to balancing
the immediate cash flow needs of the business and desire to
accelerate the project development timeframe against the need to
avoid unnecessary dilution of the shareholders during a period of
depressed equity market prices. Options ranging
from:
· project level debt or strategic equity which would provide
sufficient funding to accelerate the project development program
over the period of consideration, including the LHM refinery train
1 FEED study alongside development of the Port Hedland LSM refinery
and TVG graphite projects, as well as general working capital
requirements;
· market
equity placings to secure working capital funding needs whilst
project development funding opportunities continue to be
assessed;
· convertible lending facilities which may act as a hybrid of
working capital and project development funding, allowing
progression of project development at a less accelerated rate that
would be the case under a more substantial project lending
facility;
· any
combination of the above.
As successful execution of one of
the above fundraising options cannot be assured, a material
uncertainty exists which may cast significant doubt on the ability
of the Company and Group to continue as a going concern and realise
its assets and discharge its liabilities in the normal course of
business.
However, the Board remains in
detailed discussions on the above funding opportunities and
anticipates concluding this process in the near term. As such, the
Directors are therefore reasonably confident that the necessary
funding will be secured, as and when required, by executing on one
of the above options under consideration, such that the Directors
have a reasonable expectation that the Company will continue in
operational existence for the next 12 months.
Accordingly, the Directors believe
that as at the date of this report it is appropriate to continue to
adopt the going concern basis in preparing the financial
statements.
Financial
assets
Financial assets and financial
liabilities are recognised when the Company becomes a party to the
contractual provisions of a financial instrument. Financial assets
and financial liabilities are offset if there is a legally
enforceable right to set off the recognised amounts and interests
and it is intended to settle on a net basis. Cash comprises cash in
hand and on demand deposits. Cash equivalents are short-term,
highly liquid investments that are readily convertible to known
amounts of cash and that are subject to an insignificant risk of
changes in value with maturities of less than 90 days.
Financial
liabilities
The Company does not currently have
any financial liabilities measured at fair value through profit or
loss, therefore all financial liabilities are initially measured at
fair value, net of transaction costs, and are subsequently measured
at amortised cost. The Company recognises an equity instrument on
any contract that evidences a residual interest in the assets of
the Company. In this period Ordinary Shares were the only equity
instrument, recognised at the point at which a call is made on the
Shareholders.
Earnings per Ordinary
Share
The Company presents basic and
diluted earnings per share data for its Ordinary Shares. Basic
earnings per Ordinary Share is calculated by dividing the profit or
loss attributable to Shareholders by the weighted average number of
Ordinary Shares outstanding during the period. Diluted earnings per
Ordinary Share is calculated by adjusting the earnings and number
of Ordinary Shares for the effects of dilutive potential Ordinary
Shares.
3. USE OF ASSUMPTIONS AND
ESTIMATES
In preparing the Company Financial
Information, the Directors have to make judgments on how to apply
the Company's accounting policies and make estimates about the
future. The Directors do not consider there to be any critical
judgments that have been made in arriving at the amounts recognised
in the Company Financial Information.
4. DIRECTORS'
EMOLUMENTS
31
July 2024
|
Directors'
fees
£'000
|
Consultancy
fees
£'000
|
Social
Security
£'000
|
Total
£'000
|
P Atherley
|
26,075
|
53,500
|
3,120
|
82,695
|
S Quinn
|
19,556
|
30,000
|
2,340
|
51,896
|
H Pein
|
9,000
|
-
|
-
|
9,000
|
V Jeckel
|
18,000
|
113,000
|
2,340
|
133,340
|
Total
|
72,631
|
196,500
|
7,800
|
276,931
|
There were no staff costs other than
directors fees as no staff were employed by the Company during the
or prior period.
5. FINANCIAL RISK
MANAGEMENT
The Company uses a limited number of
financial instruments, comprising cash and various items such as
trade payables, which arise directly from operations. The Company
does not trade in financial instruments.
Financial risk factors
The Company's activities expose it
to a variety of financial risks: credit risk and liquidity risk.
The Company's overall risk management programme focuses on the
unpredictability of financial markets and seeks to minimise
potential adverse effects on the Company's financial
performance.
(a)
Credit risk
The Company does not have any major
concentrations of credit risk related to any individual customer or
counterparty.
(b)
Liquidity risk
Prudent liquidity risk management
implies maintaining sufficient cash, the Company ensures it has
adequate resource to discharge all its liabilities. The directors
have considered the liquidity risk as part of their going concern
assessment.
Fair values
Management assessed that the fair
values of other receivables approximate their carrying amounts
largely due to the short-term maturities of these
instruments.
6. CAPITAL MANAGEMENT
POLICY
The Company's objectives when
managing capital are to safeguard the Company's ability to continue
as a going concern in order to provide returns for shareholders and
benefits for other stakeholders and to maintain an optimal capital
structure to reduce the cost of capital. The capital structure of
the Company consists of equity attributable to equity holders of
the Company, comprising issued share capital and
reserves.
7. FINANCIAL
INSTRUMENTS
The Company's principal financial
instruments comprise other receivables. The Company's accounting
policy and method adopted, including the criteria for recognition,
the basis on which income and expenses are recognised in respect of
this financial asset. The Company does not use financial
instruments for speculative purposes.
There are no financial assets that
are either past due or impaired.
8. TRADE AND OTHER
RECEIVABLES
|
31 July
2024
|
31 July
2023
|
|
£
|
£
|
Prepayments
|
29,982
|
68,207
|
VAT receivable
|
65,193
|
97,117
|
Other receivables
|
2,574
|
226,974
|
Total trade and other receivables
|
97,749
|
392,298
|
9. EARNINGS PER
SHARE
The loss per share has been
calculated using the loss for the year and the weighted average
number of ordinary shares entitled to dividend rights which were
outstanding during the year. There were no potentially dilutive
ordinary shares at the year end.
|
31 July
2024
|
31 July
2023
|
|
£
|
£
|
Loss for the period attributable to equity holders of the
Company
|
(677,049)
|
(1,066,646)
|
Weighted average number of ordinary shares (number of
shares)
|
8,814,851
|
7,199,998
|
Loss per share (pence
per
share)
|
(7.7)
|
(14.8)
|
10. SHARE CAPITAL &
RESERVES
|
Number of ordinary shares of
2p
|
Share
Capital
£
|
Share
premium
£
|
Shares to
issue
£
|
Share based
payments
£
|
At
31 January 2023
|
7,199,998
|
144,000
|
2,413,243
|
-
|
63,221
|
Shares to issue
|
-
|
-
|
-
|
872,162
|
-
|
Issue of Options and
Warrants
|
-
|
-
|
-
|
-
|
62,832
|
At
31 July 2023
|
7,199,998
|
144,000
|
2,413,243
|
872,162
|
126,053
|
At
31 January 2024
|
8,814,851
|
176,297
|
4,261,627
|
-
|
259,771
|
Issue of Options and
Warrants
|
-
|
-
|
-
|
-
|
118,020
|
At
31 January 2024
|
8,814,851
|
176,297
|
4,261,627
|
-
|
337,791
|
On 31 May 2023 the Company entered
into a loan arrangement with Paul Atherley for £920,800 in gross
funding (£872,162 net of costs) to be repaid in a fixed number of
ordinary shares in the Company, at a fixed price, at a future date.
Under IFRS, the terms of this loan required it to be recorded as an
equity reserve "shares to issue" as the economic risks of the
instrument are more closely aligned to equity than debt, with
transactions costs being taken as a deduction from this equity
reserve. As a consequence these net amounts received as at
the prior period reporting date were recognised in the "shares to
issue" reserve. On issuance of the repayment shares, which
took place on 5 October 2023, these amounts were reallocated to the
share capital and share premium reserves.
No further issues of Ordinary Shares
were made during the period.
11. TRADE AND OTHER PAYABLES
|
31 July
2024
£
|
31 July
2023
£
|
Trade payables
|
697,574
|
1,011,480
|
Other payables
|
72,521
|
123,996
|
Accrued expenses
|
331,902
|
187,972
|
Total trade and other payables
|
1,101,997
|
1,323,448
|
12. POST BALANCE SHEET EVENTS
On 5 August 2024, the Company
granted 500,000 options to directors and advisors as part of an
incentivisation package linked to the achievement of the securing
funding to complete the FEED study for the Company's LHM
refinery. The options have an exercise price of nil, expiry
period of 5 years and become exercisable once the funding required
for the completion of the FEED study has been fully
secured.
Details of the allocation of the
above options are as follows:
Receiving Party
|
Number of options
|
|
|
Paul Atherley
|
150,000
|
Sam Quinn
|
150,000
|
Vikki Jeckell
|
150,000
|
Helen Pein
|
25,000
|
Consultants - non board
|
25,000
|
|
|
Total
|
500,000
|
13. ULTIMATE CONTROLLING PARTY
As at 31 July 2024, the company has
no ultimate controlling party.